SCM
HZNP

Scopia Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Scopia Capital Management’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-473,575
Closed -$26.3M – 26
2020
Q2 		$26.3M Sell
473,575
-790,827
-63% -$33.8M 2.9% 13
2020
Q1 		$37.5M Sell
1,264,402
-1,263,054
-50% -$42.7M 3.43% 10
2019
Q4 		$91.5M Sell
2,527,456
-1,694,129
-40% -$51.9M 7.09% 5
2019
Q3 		$115M Sell
4,221,585
-66,902
-2% -$1.73M 6.73% 7
2019
Q2 		$103M Sell
4,288,487
-3,870,697
-47% -$98.2M 4.58% 9
2019
Q1 		$216M Sell
8,159,184
-2,566,458
-24% -$60.8M 7.97% 5
2018
Q4 		$210M Sell
10,725,642
-4,036,712
-27% -$79.1M 7.11% 5
2018
Q3 		$289M Buy
14,762,354
+2,850,064
+24% +$54.2M 5.56% 5
2018
Q2 		$197M Sell
11,912,290
-3,251,063
-21% -$49.6M 3.45% 11
2018
Q1 		$215M Sell
15,163,353
-1,207,011
-7% -$17.8M 4.31% 7
2017
Q4 		$239M Buy
16,370,364
+254,675
+2% +$3.58M 4.29% 7
2017
Q3 		$204M Buy
16,115,689
+807,546
+5% +$10.3M 3.23% 11
2017
Q2 		$182M Buy
15,308,143
+5,621,881
+58% +$69.9M 3.75% 9
2017
Q1 		$143M Buy
9,686,262
+1,604,612
+20% +$26M 2.64% 13
2016
Q4 		$131M Buy
+8,081,650
New +$147M 2.48% 13

Other funds holding HZNP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Scopia Capital Management's HZNP Position: Q3 2020 in Review

Scopia Capital Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2020, closing a stake of 473,575 shares — an estimated $26.3M sold.

Scopia Capital Management first reported a position in HZNP in Q4 2016 and held it in 15 quarters. The position peaked at $289M in Q3 2018. 433 funds tracked by Wall St. Rank hold HZNP as of Q3 2020.

  • Scopia Capital Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2020 after selling out during the quarter.
  • Scopia Capital Management sold 473,575 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2020, an estimated $26.3M.
  • Scopia Capital Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2016 and held it in 15 quarters.
  • Scopia Capital Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $289M in Q3 2018.
  • 433 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2020.

Based on Scopia Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.